CA2375673C - Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene - Google Patents

Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene Download PDF

Info

Publication number
CA2375673C
CA2375673C CA002375673A CA2375673A CA2375673C CA 2375673 C CA2375673 C CA 2375673C CA 002375673 A CA002375673 A CA 002375673A CA 2375673 A CA2375673 A CA 2375673A CA 2375673 C CA2375673 C CA 2375673C
Authority
CA
Canada
Prior art keywords
hpv39
nucleotide
dna
sequence
chosen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002375673A
Other languages
English (en)
French (fr)
Other versions
CA2375673A1 (fr
Inventor
Gerard Orth
Christoph Volpers
Rolf E. Streeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CA2375673A1 publication Critical patent/CA2375673A1/fr
Application granted granted Critical
Publication of CA2375673C publication Critical patent/CA2375673C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002375673A 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene Expired - Lifetime CA2375673C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FRFR90/16044 1990-12-20
FR9016044A FR2670797A1 (fr) 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
CA002098819A CA2098819C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002098819A Division CA2098819C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene

Publications (2)

Publication Number Publication Date
CA2375673A1 CA2375673A1 (fr) 1992-07-09
CA2375673C true CA2375673C (fr) 2005-05-17

Family

ID=9403488

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002375673A Expired - Lifetime CA2375673C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
CA002098819A Expired - Lifetime CA2098819C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002098819A Expired - Lifetime CA2098819C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene

Country Status (10)

Country Link
US (2) US5656423A (Direct)
EP (1) EP0563255B1 (Direct)
JP (1) JP3859696B2 (Direct)
AT (1) ATE112316T1 (Direct)
CA (2) CA2375673C (Direct)
DE (1) DE69104380T2 (Direct)
DK (1) DK0563255T3 (Direct)
ES (1) ES2062887T3 (Direct)
FR (1) FR2670797A1 (Direct)
WO (1) WO1992011369A1 (Direct)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
MXPA01004287A (es) * 1998-10-26 2002-06-04 Ventana Med Syst Inc Deteccion del virus del papiloma humano en frotis de papanicolau (pap).
US7569344B2 (en) * 1998-10-26 2009-08-04 Ventana Medical Systems, Inc. Detection of human papilloma virus in papanicolaou (Pap) smears
AU778737B2 (en) * 1999-04-14 2004-12-16 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US20060275784A1 (en) * 1999-10-26 2006-12-07 Ventana Medical Systems, Inc. Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears
US20040229298A1 (en) * 2000-11-11 2004-11-18 Lu Peter S. Methods and compositions for treating cervical cancer
US7312041B2 (en) * 2001-02-16 2007-12-25 Arbor Vita Corporation Methods of diagnosing cervical cancer
WO2003008649A1 (en) * 2001-07-20 2003-01-30 Board Of Regents, The University Of Texas System Methods and compositions relating to hpv-associated pre-cancerous and cancerous growths, including cin
US7704965B2 (en) * 2002-06-26 2010-04-27 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
EP2026070A1 (en) 2002-09-09 2009-02-18 Arbor Vita Corporation Methods of diagnosing cervical cancer
CA2539703C (en) * 2003-09-25 2011-06-07 Third Wave Technologies, Inc. Detection of human papilloma virus (hpv) utilizing invasive cleavage structure assays
US7399467B2 (en) 2003-12-23 2008-07-15 Arbor Vita Corporation Antibodies for oncogenic strains of HPV and methods of their use
AU2005314061B2 (en) 2004-12-08 2010-01-28 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
WO2006060872A1 (en) * 2004-12-10 2006-06-15 Genera Biosystems Pty Ltd Human papilloma virus (hpv) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (facs)
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
US8859218B2 (en) * 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
EP2142926B1 (en) * 2007-04-05 2012-12-05 Genera Biosystems Limited Compositions and methods of detection
GB0820822D0 (en) * 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
CN102449479B (zh) 2009-05-07 2015-11-25 安科健康公司 鉴别高度或≥cin2用于人乳头瘤病毒(hpv)与hpv相关癌症的早期及晚期检测、筛检和诊断
WO2011084598A1 (en) 2010-01-08 2011-07-14 Oncohealth Corporation High throughput cell-based hpv immunoassays for diagnosis and screening of hpv-associated cancers
WO2011149897A1 (en) * 2010-05-25 2011-12-01 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593828B2 (fr) * 1986-01-31 1990-05-04 Pasteur Institut Sonde a papillomavirus et procede de diagnostic in-vitro d'infections a papillomavirus
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
US5182377A (en) * 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
FR2641081A1 (Direct) * 1988-12-23 1990-06-29 Medgenix Group

Also Published As

Publication number Publication date
ATE112316T1 (de) 1994-10-15
CA2098819C (fr) 2002-06-18
EP0563255B1 (fr) 1994-09-28
DE69104380D1 (de) 1994-11-03
JPH06504672A (ja) 1994-06-02
WO1992011369A1 (fr) 1992-07-09
US5665535A (en) 1997-09-09
DE69104380T2 (de) 1995-02-09
ES2062887T3 (es) 1994-12-16
JP3859696B2 (ja) 2006-12-20
US5656423A (en) 1997-08-12
CA2098819A1 (fr) 1992-06-21
EP0563255A1 (fr) 1993-10-06
DK0563255T3 (da) 1994-10-24
CA2375673A1 (fr) 1992-07-09
FR2670797A1 (fr) 1992-06-26
FR2670797B1 (Direct) 1994-08-19

Similar Documents

Publication Publication Date Title
CA2375673C (fr) Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
EP0462187B1 (fr) Composition pharmaceutique, utile a titre preventif ou curatif contre les tumeurs induites par les papillomavirus
EP0342128B1 (fr) Sondes à papillomavirus (HPV49, HPV50, HPV54, HPV55), produits génétiquement et immunologiquement liés à ce papillomavirus et procédé de diagnostic in vitro d'infection à papillomavirus et de production d'anticorps contre ces papillomavirus
Mossadegh et al. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells
CA1279276C (fr) Polypeptides et anticorps, caracteristiques du papillomavirus et leurs applications au diagnostic in vitro a la prevention et/ou la lutte contre des infections a papillomavirus
Iftner et al. Transcription of the E6 and E7 genes of human papillomavirus type 6 in anogenital condylomata is restricted to undifferentiated cell layers of the epithelium
EP0862634B2 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
US5874089A (en) Protecting against canine oral papillomavirus (copy)
CA2112096C (fr) Sequences d'adn du papillomavirus hpv42 - application au diagnostic
US6290965B1 (en) DNA encoding human papillomavirus type 6A
Nicholls et al. Detection of viral DNA and E4 protein in basal keratinocytes of experimental canine oral papillomavirus lesions
US6395512B1 (en) DNA coding for a peptide of a papilloma virus main capside protein and use thereof
O'Banion et al. Cloning and characterization of a papillomavirus associated with papillomas and carcinomas in the European harvest mouse (Micromys minutus)
CN110862459A (zh) Hpv16e7亲和体负载颗粒酶b的亲和毒素靶向分子及其用途
EP0458668A1 (fr) Sonde à papillomavirus (HPV66), notamment pour le diagnostic in vitro d'infections à papillomavirus, pouvant s'accompagner de néoplasies génitales, et produits génétiquement et immunologiquement liés à ce papillomavirus
WO1991009866A1 (fr) Sonde a papillomavirus (hpv63), notamment pour le diagnostic in vitro d'infections a papillomavirus, pouvant s'accompagner de neoplasies genitales, et produits genetiquement et immunologiquement lies a ce papillomavirus
Rando Nucleic acid hybridization as a diagnostic tool for the detection of human papillomaviruses
Moody et al. The life cycle of human papillomaviruses
FR2631341A1 (fr) Sondes a papillomavirus hpv49, hpv50, hpv54, hpv55 et produits genetiquement et immunologiquement lies a ce papillomavirus hpv49, hpv50, hpv54, hpv55 et procede de diagnostic in vitro d'infections a papillomavirus et d'immunisation in vivo contre ces papillomavirus
Genovese The mechanism of human papillomavirus E7 protein mediated s-phase reentry in the squamous epithelium
Cruz Diversity in Papillomavirus Host Interactions During Attachment and Entry
Ryding Human Papillomavirus vaccination: Immunological and epidemiological studies

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry